Medico Remedies Ltd.

View in App
48.25 -0.23 ▼-0.5%

19 April 2024, 04:01:00 PM
Volume: 15,205

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://medicoremedies.com
Market Cap 397.58 Cr.
Enterprise Value(EV) 401.89 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.84 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 57.13 Trailing Twelve Months Ending 2023-12
Industry PE 40.73 Trailing Twelve Months Ending 2023-12
Book Value / Share 5.91 Trailing Twelve Months Ending 2023-12
Price to Book Value 8.11 Calculated using Price: 47.91
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 8.30 Cr. 82,984,000 Shares
FaceValue 2
About Medico Remedies Ltd.
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Medico Remedies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Medico Remedies Ltd. Performance

View details >>
1 Day
-0.47%
1 Week
+2.29%
1 Month
-37.91%
3 Month
-42.92%
6 Month
-32.05%
1 Year
-35.95%
2 Year
+201.56%
5 Year
+972.22%
10 Year

Medico Remedies Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.14 7.97 10.47 5.67 5.72 5.61 8.31 13.94 18.01
Return on Capital Employed (%) 10.01 10.86 9.39 9.05 7.79 7.66 10.13 15.09 21.88
Return on Assets (%) 2.36 2.78 3.47 2.26 2.31 2.15 3.43 6.24 8.63

Medico Remedies Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 14 15 16 27 28 30 32 37 44 48
Non Curr. Liab. 1 4 11 3 3 5 5 3 2 2
Curr. Liab. 22 26 21 30 45 40 38 40 43 53
Minority Int.
Equity & Liab. 36 46 48 59 76 75 76 79 89 102
Non Curr. Assets 10 9 10 14 17 19 17 20 23 22
Curr. Assets 26 37 38 46 59 57 58 59 66 81
Misc. Exp. not W/O
Total Assets 36 46 48 59 76 75 76 79 89 102

Medico Remedies Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 51 67 54 61 98 89 122 121 140 132
Other Income 0 0 0 1 2 2 1 2 4 2
Total Income 51 67 55 62 100 91 123 123 145 133
Total Expenditure -48 -63 -50 -58 -95 -86 -117 -114 -131 -120
PBIDT 3 4 4 4 5 5 6 9 14 13
Interest -1 -1 -1 -2 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -2 -2 -2 -2 -3 -3
Taxation 0 -1 0 -1 -1 -1 -1 -2 -3 -2
Exceptional Items 0
PAT 1 1 2 1 2 2 3 5 7 7
Adjusted EPS 0 0 0 0 0 0 0 1 1 1

Medico Remedies Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 0 -4 -3 5 5 1 -11 6 8
Cash Fr. Inv. -4 -2 0 -3 -5 -4 -3 -17 -2 -7
Cash Fr. Finan. 2 3 2 6 -1 -1 3 18 -6 -2
Net Change 1 0 -1 0 -1 0 0 -10 -2 0
Cash & Cash Eqvt 1 2 1 0 0 0 1 -10 1 1

Medico Remedies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34
Public 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Medico Remedies Ltd. Announcements

View details >>
Wed, 17 Apr 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And DisclosureRequirements) Regulations 2015 For The Year Ended 31St March 2024
We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations 2015 for the year ended 31st March 2024.
Mon, 15 Apr 2024
Compliance Certificate For The Year Ended On 31St March 2024 Pursuant To Regulation7(3) Of The SEBI (LODR) Regulations 2015
We hereby submit the duly signed Compliance Certificate for the year ended on 31st March 2024 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations 2015
Wed, 27 Mar 2024
Closure of Trading Window
The Trading Window for dealing in the equity shares of the Company is closed for all Insiders Designated Persons and their immediate relatives from 1st April 2024 upto the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended 31st March 2024.

Medico Remedies Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year

Medico Remedies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,310.75 1,525.00 +0.5%
Cipla Ltd. 108,622.88 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,134.26 5,942.65 -0.3%
Divi's Laboratories Ltd. 97,408.39 3,673.85 -1.2%
Mankind Pharma Ltd. 93,565.44 2,362.00 -1.5%
Zydus Lifesciences Ltd. 92,794.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 88,715.85 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.02 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.29 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.96 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 70.43 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 54.18 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.20 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 112.40 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.19 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.47 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.53 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.92 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.14 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Medico Remedies Ltd. FAQ's

What is Medico Remedies share price?
Can I buy Medico Remedies shares now?
What is the Market Cap of Medico Remedies?
What are the key metrics to analyse Medico Remedies?
What is the 52 Week High and Low of Medico Remedies?
What is the trend of Medico Remedies share price?